Eisai
4523.T
#2105
Rank
HK$53.88 B
Marketcap
HK$191.00
Share price
-4.47%
Change (1 day)
-37.55%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$16.93. In 2022 the company made an earnings per share (EPS) of HK$12.43 a decrease over its 2021 EPS that were of HK$55.16.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1037.6%
2022HK$12.43-77.48%
2021HK$55.16-41.88%
2020HK$94.91-0.94%
2019HK$95.8152.59%
2018HK$62.79124.17%
2017HK$28.01-49.42%
2016HK$55.3837.08%
2015HK$40.40-11.75%
2014HK$45.78-3.23%
2013HK$47.31-18.56%
2012HK$58.09-15.51%
2011HK$68.76-3.75%
2010HK$71.44-1.36%
2009HK$72.43